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SUMMARY The prevalence of antibody against Toxoplasma gondi in a population of 715 pregnant women has been evaluated by two methods: indirect haemagglutination antibody (IHA) and indirect fluorescent antibody (IFA) tests and all positive sera were checked by the dye test. Five hundred of the study population were questioned on diet and on animal contact to elucidate a possible relation to the prevalence of antibody.
Results are expressed in international units (IU) of antibody against Tgondi. Of the 715 sera, 171 were positive by IHA and 173 by IFA. One hundred and sixty-seven sera were positive by both tests; ninety-eight (58 %) correlating exactly, as to the concentration of antibody. The ten sera which were not positive by both tests all had detectable antibody at the minimum concentration only (12 IU) . The dye test confirmed all sera positive by both tests with the exception of three. It also confirmed one of four sera positive by IHA antibody alone and two of six positive by IFA alone. All sera that proved dye test-negative had low antibody concentrations (12 IU) Table 2 ). The majority of the latter had 50 JU of antibody against Tgondi. Larger differences are seen between the two tests in high titre sera (800 IU) than in lower titred sera. Other workers using these methods have obtained results which differed from our own both in reliability and the antibody pattern seen.45 Our work showed for example, higher results for the IHA test than the IFA test (Table 1) . However, other work suggests that this is the expected pattern. 6 Although not used in the studies mentioned above, it seems important to include a standard serum in any investigation of this kind. In our study an international reference serum was used (recommended by the WHO since 1968), for it is by the use of such controls that comparability between studies will be more easily attained. Ruoss and Bourne.9 The age-group showing the highest rate of antibody acquisition differed in all the studies mentioned above. It is important to define this age-group, for the higher the rate of antibody acquisition (primary infection) the greater will be the risk of congenital toxoplasmosis.7
From our study, the lowest incidence of congenital toxoplasmosis would be expected in children born to women aged 26-30 (40 % of the study population) and the highest incidence in those born to women aged 36-40 (67 %). Ruoss and Bourne9 found their highest estimated seroconversion rate in the 20-25 age-group and a stable low rate in the two groups 30-35 and 36-40, but the pregnant population they studied was, on the whole, much younger than our own; 47-5 % were between 15 and 20 years of age. This age distribution is markedly different from that generally seen in antenatal clinics in England and Wales and differs from that seen in this study population where the age distribution closely matched that of mothers of children born in 1976.10
We found 11 patients with a high titre of toxoplasma antibody (> 800 IU by either test), but we could not demonstrate toxoplasma-specific IgM in any. Karim and Ludlam6 presented data on antibody detected by the IFA and IHA tests which showed that the pattern of response to the antigens allows a crude dating of infection by T gondi. Using their criteria, two of our patients had an antibody pattern which suggested infection in the last six months, but our inability to demonstrate specific IgM leaves the evidence for recent infection unsupported. There was no evidence of congenital toxoplasmosis in their offspring. The titre of antibody against Tgondi has been proposed as a useful way of dating infection." While we have reservations on this proposal it does seem likely that the more recent infections will have higher titres than less recent infections. In Table 4 we set out high titre sera according to age; and this shows that the highest proportion of high titre sera occur in the age-group with the highest estimated rate of annual acquisition of antibody. The numbers are too small for statistical analysis so any conclusions must be tentative but the trend seems to support the observation that "recent" infection occurs most frequently in one of the smallest age-groups (Table 3) .
The questionnaire produced only one significant finding; the group with the highest rate of acquisition of antibody (36-40 years) showed the highest incidence of keeping cats. Ownership of cats was not a feature distinguishing antibody-positive and antibody-negative individuals overall. It may be possible to explain this apparent discrepancy by reference to the persistence of antibody against T gondi. In the high antibody acquisition group it may be assumed that more recent contact with cats exists and so is more likely to be remembered than contact in early life.
The rate of antibody acquisition in our study population was 1 2 % per annum. This is higher than that usually seen in the UK where a range of 0-5-1*0 % per annum is reported. This is lower than the 1-75 % per annum experienced in France. ' 
